Li, Changhui
Zhang, Bo
Guo, Jindong
Hu, Fang
Nie, Wei
Zheng, Xiaoxuan
Wang, Lixin
Lou, Yuqing
Shen, Yinchen
Han, Baohui
Zhang, Xueyan http://orcid.org/0000-0001-6332-5089
Funding for this research was provided by:
Science and Technology Commission of Shanghai Municipality (18441904700)
Article History
First Online: 3 July 2019
Change Date: 17 July 2019
Change Type: Correction
Change Details: The article Epidermal Growth Factor Receptor (EGFR)–Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung Adenocarcinom, written by Changhui Li, Bo Zhang, Jindong Guo, Fang Hu, Wei Nie, Xiaoxuan Zheng, Lixin Wang, Yuqing Lou, Yinchen Shen, Baohui Han, Xueyan Zhang, was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 03 July 2019 with open access. With the author(s)’ decision to step back from Open Choice, the copyright of the article changed on 17 July 2019 to © Springer Nature Switzerland AG 2019 and the article is forthwith distributed under the terms of copyright.
Compliance with Ethical Standards
:
: This study was funded by the Science and Technology Commission of Shanghai Municipality, China (No.18441904700), and the nurture projects for basic research of Shanghai Chest Hospital (No. 2018YNJCM05).
: Changhui Li, Bo Zhang, Jindong Guo, Fang Hu, Wei Nie, Xiaoxuan Zheng, Lixin Wang, Yuqing Lou, Yinchen Shen, Baohui Han, and Xueyan Zhang declare that they have no conflicts of interest that might be relevant to the content of this article.